早期非小细胞肺癌行胸腔镜下肺癌根治术疗效观察

Therapeutic effect observation of thoracoscope radical resection of lung cancer for early stage nonsmall cell lung cancer

目的探讨早期非小细胞肺癌患者行胸腔镜下肺癌根治术的临床疗效。方法 50例早期非小细胞肺癌患者,依据治疗方法不同分为对照组和观察组,各25例。对照组进行常规开胸手术治疗,观察组进行胸腔镜下肺癌根治术治疗,观察比较两组患者手术时间、出血量、引流管放置时间、住院时间及并发症发生情况。结果观察组的手术时间为(172.68±8.99)min,明显长于对照组的(152.34±10.03)min,出血量为(186.92±20.34)ml,明显少于对照组的(219.77±15.67)ml,引流管放置时间及住院时间分别为(5.42±1.96)d、(13.11±1.25)d,均明显短于对照组的(6.82±2.12)d、(15.46±2.02)d,差异具有统计学意义(P<0.05)。观察组并发症发生率为8.00%,显著低于对照组的36.00%,差异具有统计学意义(P<0.05)。结论针对早期非小细胞肺癌患者采取胸腔镜下肺癌根治术治疗可减少术中创伤,加快术后康复,并减少并发症的发生,临床治疗价值较高。

Objective To investigate the clinical efficacy of thoracoscope radical resection of lung cancer for early stage non-small cell lung cancer. Methods Fifty patients with non-small cell lung cancer were divided into control group and observation group according to different treatment methods, 25 cases in each group. The control group was treated with conventional thoracotomy, and the observation group was treated with thoracoscopic radical resection of lung cancer. The operative time, amount of bleeding, drainage tube placement time, length of stay and occurrence of complications between the two groups were observed and compared. Results The operative time of the observation group was （172.68±8.99） min, which was significantly longer than （152.34±10.03） min of the control group, the amount of bleeding of the observation group was （186.92±20.34） ml, which was significantly less than （219.77±15.67） ml of the control group, the drainage tube placement time and length of stay in the observation group were （5.42±1.96） d and （13.11±1.25） d respectively, which were significantly shorter than （6.82±2.12） d and （15.46±2.02） d in the control group, the differences were statistically significant （P〈0.05）. The occurrence of complications in the observation group was 8.00%, which was significantly lower than 36.00% in the control group, the difference was statistically significant （P〈0.05）. Conclusion Thoracoscopic radical resection of lung cancer for early stage non-small cell lung cancer can reduce intraoperative trauma, speed up postoperative rehabilitation, and reduce the incidence of complications, the clinical value of treatment is higher.